Groundbreaking New Drug Treats Hospital-Acquired Pneumonia in China
Drug-resistant Acinetobacter baumannii is a significant global health threat, and the World Health Organization (WHO) has classified it as...
Jon Napitupulu
Phastar and Beaconcure Partnership: A Revolutionary Step in Clinical Data Review
Beaconcure Inc., a leader in AI-driven clinical data validation, and Phastar Inc., a biometrics CRO, have partnered to streamline...
AmplifyBio and Xcell Biosciences: An Uncommonly Great Partnership for Cancer Therapy
Xcellbio and AmplifyBio have partnered to enhance the development and manufacturing of engineered T-cell receptor (TCR) therapies for solid...
Terran Biosciences Unveils Remarkable Breakthrough: TERXT for Schizophrenia
Terran Biosciences has developed TerXT, a combination of novel prodrugs of xanomeline and trospium, for treating schizophrenia. The prodrug...
“Clinical Trial in a Dish” Revolutionary Models for Studies
Parallel Bio, a biotechnology company, has developed “Clinical Trial in a Dish,” a revolutionary platform that employs human models...
FDA Breakthrough: Amazing Device Revolutionizes Infectious Disease Diagnosis
Karius, Inc., a pioneer in genomic diagnostics for infectious diseases, has received a Breakthrough Device designation from the FDA...
Cindome Pharma’s $40 Million Series B Extension: A Transformational Catalyst for Rare Disease Treatments
CinDome Pharma, a subsidiary of CinRx Pharma, has secured a $40 million extension to its Series B financing, raising...
AI-Powered Cell Simulations Soar in Biopharma with Accenture’s Latest Investment
Accenture Ventures, the venture capital arm of Accenture, has invested in Turbine, a predictive simulation company developing a platform...
Tezspire’s Potential Role in Chronic Obstructive Pulmonary Disease: Latest ATS Findings Revealed
A Phase IIa trial, known as COURSE, has assessed the effectiveness of TEZSPIRE (tezepelumab) in reducing COPD exacerbations in...
Sotyktu’s Power: Long-Lasting Relief in Plaque Psoriasis
New data revealed that after four years of continuous treatment, over 70% of patients with psoriasis achieved a 75%...